Company profile: Absci
1.1 - Company Overview
Company description
- Provider of an integrated drug creation platform that combines deep learning AI and synthetic biology to design, test, and validate biologic therapeutics. Services include de novo antibody design, AI-powered antibody optimization, novel target identification, and SoluPro technology to produce protein variant data, enabling rapid creation from AI-designed antibodies to wet labβvalidated candidates.
Products and services
- AI-Powered Antibody Optimization: A multiparametric AI approach evaluates and optimizes antibody variants for improved target affinity, manufacturability, and other pharmacologic characteristics
- De Novo Antibody Design: A sequence-level process generates a library of antibody sequence variants to establish target specificity, creating novel lead drug candidates with desirable attributes
- Integrated Drug Creationβ’ Platform: An integrated AI plus synthetic biology platform develops, tests, and validates biologic-based therapeutics, enabling rapid creation from AI-designed antibodies to wet lab-validated candidates.
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to Absci
Vantage Discovery
HQ: United States
Website
- Description: Provider of a generative AI-powered SaaS search and content discovery platform delivering personalized shopping recommendations and semantic search. Offers the Vantage API to shift from keyword to intent-aware search, natural language search, and More-Like-This/These similarity features based on semantic meaning and visual characteristics, enabling production-ready solutions in hours.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Vantage Discovery company profile β
Abridge
HQ: United States
Website
- Description: Provider of an AI-driven platform that transforms patient-clinician conversations into structured clinical notes for the healthcare industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Abridge company profile β
LM Studio
HQ: United States
Website
- Description: Provider of local AI applications built without dealing with dependencies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full LM Studio company profile β
Touchcast
HQ: United States
Website
- Description: Provider of a generative AI and mixed reality platform for immersive, interactive virtual and hybrid events, integrating content creation, management, and distribution. Products include Genything for generative media content (presentations, podcasts, virtual events), Ciscape for generative CMS and website personalization, and CogCache, a cognitive CDN optimizing AI model operations and Generative Web performance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Touchcast company profile β
Krea
HQ: United States
Website
- Description: Provider of a browser-based design platform that integrates generative AI models to create, edit, and customize images and videos, offering real-time image generation, video restyling, and 3D object creation to produce and refine visual content tailored to unique styles, concepts, or products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Krea company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for Absci
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Absci
2.2 - Growth funds investing in similar companies to Absci
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for Absci
4.2 - Public trading comparable groups for Absci
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β